Article Information
History
- May 24, 2024.
Article Versions
- Version 1 (March 17, 2023 - 14:36).
- You are currently viewing Version 2 of this article (May 24, 2024 - 07:13).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- G.L. Barlow1,2,†,
- C.M Schürch2,4,
- S.S. Bhate2,
- D. Phillips2,
- A. Young3,6,7,
- S. Dong3,5,
- HA. Martinez1,
- G. Kaber1,
- N. Nagy1,
- S. Ramachandran1,
- J. Meng1,
- E. Korpos9,
- J.A. Bluestone8,†,
- G.P. Nolan2,† and
- P.L. Bollyky1,†,‡
- 1Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
- 2Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
- 3Diabetes Center, University of California San Francisco, San Francisco, CA 94143, USA
- 4Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center, Tübingen, Germany
- 5Sean N. Parker Autoimmune Research Laboratory and Diabetes Center, University of California San Francisco, San Francisco, CA, USA
- 6Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA
- 7Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
- 8Sonoma Biotherapeutics, South San Francisco, CA 94080 USA
- 9Institute of Physiological Chemistry and Pathobiochemistry and Cells-in-Motion Interfaculty Center, University of Muenster, Germany
- ↵†Corresponding Author Email: grahaml_barlow{at}dfci.harvard.edu Paul Bollyky (pbollyky{at}stanford.edu).
Posted May 24, 2024.
